Clinical Trial Update: Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) [Phase 3]

View source ↗

Summary

Phase 3 trial for brimonidine tartrate nanoemulsion eye drops in dry eye disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Syndrome

Drugs mentioned

• Brimonidine tartrate nanoemulsion eye drop solution (brimonidine tartrate)

Snippet

Sponsor: Ocugen | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2022-06-06